Abstract
It is known that when two populations of cytotoxic T lymphocytes (CTL) are mixed in conditions where antigen recognition can occur in only one direction, killing also proceeds only in the same direction1,2. These data suggest that occupancy of the T-cell receptor (TCR) is required for the expression of the lytic function by effector CTL, but do not establish whether the TCR itself has a role in the killing process. In particular, it is not clear whether the TCR is involved in the actual delivery of the lethal hit to the target cell (either being itself part of the lytic machinery or directing it), or whether TCR occupancy only serves the function of triggering a set of lytic reactions which are themselves nonspecific and not directed by the TCR. The use of mitogenic lectins or mitogenic antibodies, which bypass specific recognition and induce nonspecific killing3–5, also does not help to clarify this issue, since a necessary characteristic of these ligands is that they bind to the TCR complex or to other ‘triggering’ molecules and probably bridge these structures to the target cell6,7. The present study describes an in vitro system using human T-cell clones which allows us to dissociate the triggering of a CTL from the delivery of the lethal hit, using no externally added ligands. We report that, once triggered by recognition of the specific target, a CTL can kill any other cell that binds to it, indicating that TCR occupancy is required for triggering, but not for the delivery of the lethal hit.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kuppers, R. C. & Henney, C. S. J. exp. Med. 143, 684–689 (1976).
Fishelson, Z. & Berke, G. J. Immun. 120, 1121–1126 (1978).
Bevan, M. J. & Cohn, M. J. Immun. 114, 559–565 (1975).
Leeuwenberg, J., Spits, M., Tax, W. & Capel, P. J. Immun. 134, 3770–3775 (1985).
Siliciano, R. F., Pratt, J. C., Schmidt, R. E., Ritz, J. & Reinherz, E. L. Nature 317, 429–430 (1985).
Chilson, O. P., Boylston, A. W. & Crumpton, M. J. EMBO J. 3, 3239–3245 (1984).
O'Flynn, K., Krensky, A. M., Beverly, P. C. L., Burakoff, J. T. & Linch, D. C. Nature 313, 686–687 (1985).
Dennert, G. & Podack, E. R. J. exp. Med. 157, 1483–1495 (1983).
Henkart, P. A., Millard, P. J., Reynolds, C. W. & Henkart, M. P. J. exp. Med. 160, 75–93 (1984).
Hercend, T. et al. Eur. J. Immun. 14, 844–852 (1984).
Rammensee, H. G., Bevan, M. J. & Fink, P. J. Immun. Today 6, 41–43 (1985).
Lanzavecchia, A. Nature 314, 537–539 (1985).
Lanzavecchia, A., Parodi, B. & Celada, F. Eur. J. Immun. 13, 733–738 (1983).
Brunner, K. T., Mauel, J., Cerottini, J. C. & Chapuis, B. Immunology 14, 181–196 (1968).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lanzavecchia, A. Is the T-cell receptor involved in T-cell killing?. Nature 319, 778–780 (1986). https://doi.org/10.1038/319778a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/319778a0
This article is cited by
-
The immune system view of the coronavirus SARS-CoV-2
Biology Direct (2020)
-
Lymphokine activated killer cells
Blut (1989)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.